Cancer Theranostics, Second Edition
- 2nd Edition - August 1, 2025
- Imprint: Academic Press
- Editors: Xiaoyuan Chen, Jingjing Zhang, Stephen Wong
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 2 2 5 3 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 2 2 5 4 - 2
Cancer Theranostics, Second Edition provide updates on new molecular imaging probes and techniques for early detection of cancer and describes molecular imaging-guided cancer th… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteCancer Theranostics, Second Edition provide updates on new molecular imaging probes and techniques for early detection of cancer and describes molecular imaging-guided cancer therapy. Discussions also include nanoplatforms, incorporating both cancer imaging and therapeutic components, as well as clinical translation and future perspectives. New to this edition is the inclusion of recent developments and a streamlined structure that leads the reader through the content more intuitively, from problem to solution. More illustrations of different forms of cancer theranostics are included, and this edition also contains completely new content on DNA and RNA theranostics. In addition, new case studies are featured.
This new edition is published in time to meet the needs of medical researchers in a comprehensive manner, encompassing diagnostics, in vivo imaging and its use for image-guided therapy, and a variety of other miscellaneous subjects. This book is a must-have for all research scientists, medical physicists, and physician scientists in cancer experimental therapeutics and molecular imaging.
- Describes the identification of novel biomarkers to advance molecular diagnostics of cancer
- Includes the latest developments in liquid biopsy, new imaging techniques such as magnetic particle imaging, artificial intelligence, different types of image-guided interventions and drug delivery, and new forms of theranostics, including the most recent mRNA based theranostics
- Gives various, novel forms of cancer interventions and treatments
- Provides clinical translation of different types of cancer theranostics platforms
Research scientists, medical physicists, and physician scientists in cancer experimental therapeutics and molecular imaging Clinicians, researchers, clinical fellows and graduate students interested in nanobiotechnology, nuclear medicine, pathology, cardiology, diagnostic radiology, interventional radiology, minimum invasive surgery, etc
1. Cancer theranostics – An updated introduction
Part 1: In Vitro Diagnostics
2. Tissue specimen and liquid biopsy testing for cancer diagnostics
3. Circulating tumor cells and cancer associated fibroblasts in IVD of cancer
4. Extracellular vesicle-based IVD of cancer
5. Non-coding RNAs in cancer diagnosis
6. Circulating tumor DNA technology in cancer diagnosis
7. Nanotechnology in IVD of cancer
Part 2: Anatomical, Functional and Molecular Imaging in Cancer Theranostics
8. Radionuclide imaging of cancer
9. Luminescence imaging of cancer
10. MRI and MPI of cancer
11. Ultrasound and photoacoustic imaging of cancer
12. Raman spectroscopy and imaging for cancer diagnosis
13. OCT and OCE of cancer
14. Artificial intelligence in cancer imaging
Part 3 Image-Guided Cancer Therapy
15. Image-guided radiation therapy (IGRT) of cancer
16. Image-guided surgery (IGS) of cancer
17. Image-guided thermal ablation of cancer
18. Image-guided cancer drug delivery
Part 4: Theranostics Platforms
19. Radiotheranostics
20. Magnetotheranostics
21. Immunotheranostics
22. Optotheranostics
23. Sonotheranostics
24. RNA theranostics
25. DNA theranostics
Part 5: Production, regulations and translations of theranostics
26. Scale-up production of theranostic formulas
27. Clinical translation and regulations of theranostics
Part 1: In Vitro Diagnostics
2. Tissue specimen and liquid biopsy testing for cancer diagnostics
3. Circulating tumor cells and cancer associated fibroblasts in IVD of cancer
4. Extracellular vesicle-based IVD of cancer
5. Non-coding RNAs in cancer diagnosis
6. Circulating tumor DNA technology in cancer diagnosis
7. Nanotechnology in IVD of cancer
Part 2: Anatomical, Functional and Molecular Imaging in Cancer Theranostics
8. Radionuclide imaging of cancer
9. Luminescence imaging of cancer
10. MRI and MPI of cancer
11. Ultrasound and photoacoustic imaging of cancer
12. Raman spectroscopy and imaging for cancer diagnosis
13. OCT and OCE of cancer
14. Artificial intelligence in cancer imaging
Part 3 Image-Guided Cancer Therapy
15. Image-guided radiation therapy (IGRT) of cancer
16. Image-guided surgery (IGS) of cancer
17. Image-guided thermal ablation of cancer
18. Image-guided cancer drug delivery
Part 4: Theranostics Platforms
19. Radiotheranostics
20. Magnetotheranostics
21. Immunotheranostics
22. Optotheranostics
23. Sonotheranostics
24. RNA theranostics
25. DNA theranostics
Part 5: Production, regulations and translations of theranostics
26. Scale-up production of theranostic formulas
27. Clinical translation and regulations of theranostics
- Edition: 2
- Published: August 1, 2025
- Imprint: Academic Press
- No. of pages: 600
- Language: English
- Hardback ISBN: 9780443222535
- eBook ISBN: 9780443222542
XC
Xiaoyuan Chen
Xiaoyuan (Shawn) Chen, PhD, is a Senior Investigator and Chief of the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH). He is also founding editor of journal Theranostics. He holds a PhD in Chemistry from the University of Idaho.
Affiliations and expertise
Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of HealthJZ
Jingjing Zhang
Dr. Zhang is Assistant Professor (Tenure Track) at the Yong Loo Lin School of Medicine, National University of Singapore. She has published more than 50 peer-reviewed articles (more than 15 peer-reviewed articles in top-ranking journal JNM) in the most reputed scientific journals in the respective field. She was awarded the prestigious Thomas O’Dorisio Young Investigator Award (only 1 awardee every two years world-wide), one of TOP thirty early career professionals who stand out as “Ones to Watch” by the SNMMI, as well as Majd-Gilday Investigator Award from SNMMI, etc., and serves on the editorial board of Clin Nucl Med (IF 10.782) and is the only editorial board member from Singapore. She currently serves as Dean of Research of International Centers for Precision Oncology (ICPO) Academy, Germany
Affiliations and expertise
Yong Loo Lin School of Medicine, National University of Singapore, SingaporeSW
Stephen Wong
Stephen T.C. Wong, PhD (Computer Science), PE (Electrical Engineering), is John S. Dunn Distinguished Endowed Chair of Biomedical Engineering at Houston Methodist Hospital, the Founding Chair of Department of Systems Medicine and Bioengineering at Houston Methodist Research Institute, and a Professor of Radiology, Neurosciences, Pathology, and Laboratory Medicine at Weill Cornell Medical College.
Affiliations and expertise
Methodist Hospital Research Institute, TX, USA